UMULINE NPH 100 IU/ml, suspension for injection in a vial bottle, 10 ml
Active ingredients: INSULINE HUMAINE RECOMBINANTE ISOPHANE
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionbottle, 10 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- UMULINE NPH 100 UI/mL, suspension injectable en flacon
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- LILLY FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67340490CIP73352343CIP133400933523435Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INSULINE HUMAINE RECOMBINANTE ISOPHANEsuspension | 100 UI · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.